Medical devices, healthcare technology and the business of care
510(k) clearance · K261612

SwiftSight-BodyComposition

Airs Medical, Inc. · Decision date Oct 1, 2026

MEDTECHLEDGER EXPLANATIONK261612

What did the FDA decide?

FDA recorded a substantially equivalent (SESE) decision for SwiftSight-BodyComposition, a traditional 510(k) submitted by Airs Medical, Inc. of Seoul, KR, under 510(k) number K261612. The record lists the device classification name as System, Nuclear Magnetic Resonance Imaging, regulation number 892.1000, and primary product code LNH, with QIH as a subsequent product code. The application was received 05/15/2026 and decided 10/01/2026; the review panel and medical specialty are both Radiology.

SESE means the submission was cleared as substantially equivalent to a predicate device; it is not a PMA approval. The record states the submission was not reviewed by a third party, is not a combination product, and has no authorized Predetermined Change Control Plan. The public record does not describe the specific components, software functions, or changed items covered by the clearance, and no decision statement text is included, so the scope of what was cleared remains unknown from this source.

Regulatory pathway
510(k) premarket notification
Clinical specialty
Radiology
Decision date
Oct 1, 2026

FDA source record · MedtechLedger’s explanation describes the recorded change.

Regulatory record facts

Identifier
K261612
Regulatory pathway
510(k) premarket notification
Product code
LNH
Decision code
SESE
Decision date
Oct 1, 2026
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: System, Nuclear Magnetic Resonance Imaging.

Product code
LNH
FDA device class
2

FDA decision timeline

  1. K261612 received

    Application receipt date recorded by FDA.

  2. K261612 · FDA decision

    SESE

Related devices and submissions

Explore the linked device profile

Other records with product code LNH

Product / regulatory recordCompanyPathwayDecision dateSource
Siemens Healthineers AG510(k) clearanceNov 5, 2026FDA
Fujifilm Corporation510(k) clearanceOct 9, 2026FDA
Vista AI, Inc.510(k) clearanceOct 7, 2026FDA
Fujifilm Corporation510(k) clearanceSep 16, 2026FDA
Aspect Imaging, Ltd.510(k) clearanceSep 16, 2026FDA

A shared product code identifies a classification relationship; it does not establish clinical equivalence.

Regulatory context

A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Airs Medical, Inc.

Headquarters
Not reported
Brand website
Not reported
FDA applicant address
Seoul

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records